Pharmafile Logo

Jennifer Helfer

- PMLiVE

Pharma’s reputation rises, but pricing still a sore point

Patient group survey sees the industry's corporate reputation increase

- PMLiVE

The new EU clinical trial lay summaries

New regulations will require both a trial summary and a lay person’s summary

The new EU clinical trial lay summaries

New regulations will require both a trial summary and a lay person’s summary

- PMLiVE

Changing behaviour by design

Are we underestimating the power of design in encouraging behaviours for the good of our health?

- PMLiVE

A five-step plan for patient-centred digital communications

Every functional area should be able to interact with patients

- PMLiVE

Reflections on marketing excellence

Looking back over 20 years of change in pharma marketing

- PMLiVE

Truly, madly, cheaply

The ongoing rhetoric of patient-centricity

- PMLiVE

Avoiding an Authenticity Gap in healthcare communications

Successful companies align their brand with their reputation

- PMLiVE

Challenging perceptions

Alvaro Herreros on the ADHD landscape

Not as we know it

We shouldn’t expect our descendants to look like us

- PMLiVE

It’s behind you!

Healthcare IT problems should provide some warning signs for pharma

Harnessing complexity

Companion diagnostics in oncology

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links